These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30868525)
1. Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions. Taylor MC; Francisco AF; Jayawardhana S; Mann GS; Ward AI; Olmo F; Lewis MD; Kelly JM Methods Mol Biol; 2019; 1955():147-163. PubMed ID: 30868525 [TBL] [Abstract][Full Text] [Related]
2. Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping. Costa FC; Francisco AF; Jayawardhana S; Calderano SG; Lewis MD; Olmo F; Beneke T; Gluenz E; Sunter J; Dean S; Kelly JM; Taylor MC PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006388. PubMed ID: 29608569 [TBL] [Abstract][Full Text] [Related]
3. In Situ Detection of Dormant Trypanosoma cruzi Amastigotes Using Bioluminescent-Fluorescent Reporters. Sánchez-Valdéz F; Padilla A Methods Mol Biol; 2019; 1955():179-186. PubMed ID: 30868527 [TBL] [Abstract][Full Text] [Related]
4. Ward AI; Lewis MD; Khan AA; McCann CJ; Francisco AF; Jayawardhana S; Taylor MC; Kelly JM mBio; 2020 Aug; 11(4):. PubMed ID: 32753495 [TBL] [Abstract][Full Text] [Related]
5. Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug Activity. Taylor MC; Ward AI; Olmo F; Francisco AF; Jayawardhana S; Costa FC; Lewis MD; Kelly JM Curr Pharm Des; 2021; 27(14):1733-1740. PubMed ID: 33234096 [TBL] [Abstract][Full Text] [Related]
6. A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging. Silberstein E; Serna C; Fragoso SP; Nagarkatti R; Debrabant A PLoS One; 2018; 13(4):e0195879. PubMed ID: 29672535 [TBL] [Abstract][Full Text] [Related]
7. A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research. Olmo F; Jayawardhana S; Khan AA; Langston HC; Francisco AF; Atherton RL; Ward AI; Taylor MC; Kelly JM; Lewis MD PLoS Negl Trop Dis; 2024 May; 18(5):e0012106. PubMed ID: 38820564 [TBL] [Abstract][Full Text] [Related]
9. Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Lewis MD; Fortes Francisco A; Taylor MC; Burrell-Saward H; McLatchie AP; Miles MA; Kelly JM Cell Microbiol; 2014 Sep; 16(9):1285-300. PubMed ID: 24712539 [TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection. Henriques C; Henriques-Pons A; Meuser-Batista M; Ribeiro AS; de Souza W Parasit Vectors; 2014 Mar; 7():89. PubMed ID: 24589192 [TBL] [Abstract][Full Text] [Related]
11. Transmigration of Trypanosoma cruzi Trypomastigotes through 3D Spheroids Mimicking Host Tissues. Rodríguez ME; Rizzi M; Caeiro L; Masip Y; Sánchez DO; Tekiel V Methods Mol Biol; 2019; 1955():165-177. PubMed ID: 30868526 [TBL] [Abstract][Full Text] [Related]
12. A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging. Lewis MD; Francisco AF; Taylor MC; Kelly JM J Biomol Screen; 2015 Jan; 20(1):36-43. PubMed ID: 25296657 [TBL] [Abstract][Full Text] [Related]
13. Bioluminescent imaging of Trypanosoma cruzi infection in Rhodnius prolixus. Henriques C; Castro DP; Gomes LH; Garcia ES; de Souza W Parasit Vectors; 2012 Sep; 5():214. PubMed ID: 23013827 [TBL] [Abstract][Full Text] [Related]
14. Ward AI; Olmo F; Atherton RL; Taylor MC; Kelly JM Open Biol; 2020 Dec; 10(12):200261. PubMed ID: 33321060 [TBL] [Abstract][Full Text] [Related]
15. Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection. Taylor MC; Ward A; Olmo F; Jayawardhana S; Francisco AF; Lewis MD; Kelly JM PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008007. PubMed ID: 32196491 [TBL] [Abstract][Full Text] [Related]
17. Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection. Mann GS; Francisco AF; Jayawardhana S; Taylor MC; Lewis MD; Olmo F; de Freitas EO; Leoratti FMS; López-Camacho C; Reyes-Sandoval A; Kelly JM PLoS Negl Trop Dis; 2020 Apr; 14(4):e0007717. PubMed ID: 32302312 [TBL] [Abstract][Full Text] [Related]
18. The marsupial trypanosome Trypanosoma copemani is not an obligate intracellular parasite, although it adversely affects cell health. Cooper C; Andrew Thompson RC; Rigby P; Buckley A; Peacock C; Clode PL Parasit Vectors; 2018 Sep; 11(1):521. PubMed ID: 30236162 [TBL] [Abstract][Full Text] [Related]
19. Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy. Lewis MD; Francisco AF; Taylor MC; Jayawardhana S; Kelly JM Cell Microbiol; 2016 Oct; 18(10):1429-43. PubMed ID: 26918803 [TBL] [Abstract][Full Text] [Related]
20. Experimental evidences that P21 protein controls Trypanosoma cruzi replication and modulates the pathogenesis of infection. Teixeira TL; Castilhos P; Rodrigues CC; da Silva AA; Brígido RT; Teixeira SC; Borges BC; Dos Santos MA; Martins FA; Santos PCF; Servato JPS; Silva MS; da Silva MJB; Elias MC; da Silva CV Microb Pathog; 2019 Oct; 135():103618. PubMed ID: 31310832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]